Q2 2022

Source filing unavailable

Q2 2022 · —

Revenue

$45.17K

no prior Q2 2021 on file

Net Income

-$2.15M

no prior Q2 2021 on file

EPS Diluted

-$0.96

no prior Q2 2021 on file

Operating Income-$686,919—

Margins · derived

Operating margin-1520.6%

Net margin-4752.6%

Same quarter

no prior Q2 2021 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

60 Degrees Pharmaceuticals, Inc. · CIK 1946563 · Engraved from SEC EDGAR